A

pair of religious organizations that own stock in Vertex Pharmaceuticals is pressuring the company to disclose more information about its lobbying efforts, the latest bid by such groups to force the pharmaceutical industry to alter its business practices.

In a shareholder proposal, the organizations want the drug maker to report lobbying procedures and payments; membership in any organization that writes or endorses legislation, such as industry trade groups; and management policies for overseeing lobbying (see page 37).

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine